Chemcrux Enterprises Limited (BOM:540395)

India flag India · Delayed Price · Currency is INR
88.18
-3.18 (-3.48%)
At close: Mar 9, 2026
-30.78%
Market Cap 1.31B
Revenue (ttm) 727.43M
Net Income (ttm) 20.85M
Shares Out 14.81M
EPS (ttm) 1.41
PE Ratio 62.65
Forward PE n/a
Dividend 1.00 (1.09%)
Ex-Dividend Date Sep 17, 2025
Volume 8,306
Average Volume 5,673
Open 90.00
Previous Close 91.36
Day's Range 86.25 - 90.00
52-Week Range 86.25 - 170.00
Beta -0.29
RSI 34.54
Earnings Date May 30, 2026

About Chemcrux Enterprises

Chemcrux Enterprises Limited engages in the manufacture and sale of intermediates and chemicals in India. Its chemicals and intermediates products are used in the manufacture of bulk drugs active pharmaceutical ingredients, electro-plating, pharmaceuticals, dyes, and pigments. The company offers chloro benzoic acid, nitro benzoic acid, nitro salicylic, dichloro benzoic acid, chloro nitro benzoic acid, lasamide, arabonic acid sodium salt, chloro benzoic acid sulfonamide, BPEA sulfonamide, para and ortho chloro benzoyl chloride, and chloro benzoy... [Read more]

Industry Chemicals and Allied Products
Founded 1983
Employees 102
Stock Exchange Bombay Stock Exchange
Ticker Symbol 540395
Full Company Profile

Financial Performance

In fiscal year 2025, Chemcrux Enterprises's revenue was 706.67 million, a decrease of -10.34% compared to the previous year's 788.19 million. Earnings were 39.13 million, a decrease of -53.66%.

Financial Statements

News

There is no news available yet.